Data Last Updated: June 9, 2025

NAACCR Item #3809: AFP Pretreatment Interpretation

Item # Length Source of Standard Section Name Year Implemented Version Implemented XML NAACCR ID Parent XML Element
3809 1 NAACCR Stage/Prognostic Factors 2018 18 afpPretreatmentInterpretation Tumor
Alternate Names
  • AFP (Alpha Fetoprotein) Pretreatment Interpretation
Required Status:

NPCR Collect: No recommendation
CoC Collect: Required, site specific
SEER Collect: Collected by SEER from CoC-accredited hospitals
CCCR Collect: Required, site specific; when available

Description
AFP (Alpha Fetoprotein) Pretreatment Interpretation, a nonspecific serum protein that generally is elevated in the setting of hepatocellular carcinoma (HCC), is a prognostic factor for liver cancer.
Rationale
AFP (Alpha Fetoprotein) Pretreatment Interpretation is a Registry Data Collection Variable in AJCC. This data item was previously collected for Liver, CS SSF# 1.
Allowable Values
0-2, 7-9
Codes
Code Description
0 Negative/normal; within normal limits
1 Positive/elevated
2 Borderline; undetermined if positive or negative
7 Test ordered, results not in chart
8 Not applicable: Information not collected for this case (If this item is required by your standard setter, use of code 8 will result in an edit error.)
9 Not documented in medical record AFP pretreatment interpretation not assessed or unknown if assessed
Code Notes
Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.